Screener
Immix Biopharma, Inc. IMMX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 92,274,811 | 101,237,755 |
| Other assets | 20,418 | 20,418 |
| Deferred offering costs | 164,723 | 93,630 |
| Right-of-use asset, net | 927,728 | 966,917 |
| Property and equipment, net | 2,428,377 | 2,521,621 |
| Total assets | $95,816,057 | $104,840,341 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: |
Document
FAQ
- What is Immix Biopharma, Inc.'s operating lease ROU assets?
- Immix Biopharma, Inc. (IMMX) reported operating lease ROU assets of $927.73K in Q1 2026.
- How has Immix Biopharma, Inc.'s operating lease ROU assets changed year-over-year?
- Immix Biopharma, Inc.'s operating lease ROU assets increased by 1159659900.0% year-over-year, from $0.08 to $927.73K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Immix Biopharma, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude